Processa Pharmaceuticals, Inc. (PCSA)
2.10
-0.18
(-7.89%)
USD |
NASDAQ |
Feb 20, 16:00
2.00
-0.10
(-4.76%)
After-Hours: 20:00
Processa Pharmaceuticals SG&A Expense (Quarterly) : 1.827M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Kodiak Sciences, Inc. | 11.88M |
| Pyxis Oncology, Inc. | 5.653M |
| ACADIA Pharmaceuticals, Inc. | 133.40M |
| Alnylam Pharmaceuticals, Inc. | 325.37M |
| Savara, Inc. | 9.627M |